178 related articles for article (PubMed ID: 26864819)
21. Thrombospondin-1 mediates oncogenic Ras-induced senescence in premalignant lung tumors.
Baek KH; Bhang D; Zaslavsky A; Wang LC; Vachani A; Kim CF; Albelda SM; Evan GI; Ryeom S
J Clin Invest; 2013 Oct; 123(10):4375-89. PubMed ID: 24018559
[TBL] [Abstract][Full Text] [Related]
22. Screening for tumor suppressors: Loss of ephrin receptor A2 cooperates with oncogenic KRas in promoting lung adenocarcinoma.
Yeddula N; Xia Y; Ke E; Beumer J; Verma IM
Proc Natl Acad Sci U S A; 2015 Nov; 112(47):E6476-85. PubMed ID: 26542681
[TBL] [Abstract][Full Text] [Related]
23. Specific Ki-ras codon 61 mutations may determine the development of urethan-induced mouse lung adenomas or adenocarcinomas.
Nuzum EO; Malkinson AM; Beer DG
Mol Carcinog; 1990; 3(5):287-95. PubMed ID: 2244961
[TBL] [Abstract][Full Text] [Related]
24. Enhancement of lung carcinogenesis initiated with 4-(N-hydroxymethylnitrosamino)-1-(3-pyridyl)-1-butanone by Ogg1 gene deficiency in female, but not male, mice.
Igarashi M; Watanabe M; Yoshida M; Sugaya K; Endo Y; Miyajima N; Abe M; Sugano S; Nakae D
J Toxicol Sci; 2009 Apr; 34(2):163-74. PubMed ID: 19336973
[TBL] [Abstract][Full Text] [Related]
25. Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induces phosphorylation of mu- and m-calpain in association with increased secretion, cell migration, and invasion.
Xu L; Deng X
J Biol Chem; 2004 Dec; 279(51):53683-90. PubMed ID: 15471877
[TBL] [Abstract][Full Text] [Related]
26. Increased susceptibility of mice lacking Clara cell 10-kDa protein to lung tumorigenesis by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a potent carcinogen in cigarette smoke.
Yang Y; Zhang Z; Mukherjee AB; Linnoila RI
J Biol Chem; 2004 Jul; 279(28):29336-40. PubMed ID: 15148323
[TBL] [Abstract][Full Text] [Related]
27. High oleic acid oil suppresses lung tumorigenesis in mice through the modulation of extracellular signal-regulated kinase cascade.
Yamaki T; Yano T; Satoh H; Endo T; Matsuyama C; Kumagai H; Miyahara M; Sakurai H; Pokorny J; Shin SJ; Hagiwara K
Lipids; 2002 Aug; 37(8):783-8. PubMed ID: 12371749
[TBL] [Abstract][Full Text] [Related]
28. Survivin knockdown induces senescence in TTF‑1-expressing, KRAS-mutant lung adenocarcinomas.
Sumi T; Hirai S; Yamaguchi M; Tanaka Y; Tada M; Yamada G; Hasegawa T; Miyagi Y; Niki T; Watanabe A; Takahashi H; Sakuma Y
Int J Oncol; 2018 Jul; 53(1):33-46. PubMed ID: 29658609
[TBL] [Abstract][Full Text] [Related]
29. Estrogen receptor alpha promotes smoking-carcinogen-induced lung carcinogenesis via cytochrome P450 1B1.
Li MY; Liu Y; Liu LZ; Kong AW; Zhao Z; Wu B; Long X; Wu J; Ng CS; Wan IY; Du J; Mok TS; Underwood MJ; Chen GG
J Mol Med (Berl); 2015 Nov; 93(11):1221-33. PubMed ID: 26041383
[TBL] [Abstract][Full Text] [Related]
30. A correction to the research article titled: "Amplification of the driving oncogene, KRAS or BRAF, underpins acquired resistance to MEK1/2 inhibitors in colorectal cancer cells" by A. S. Little, K. Balmanno, M. J. Sale, S. Newman, J. R. Dry, M. Hampson, P. A. W. Edwards, P. D. Smith, S. J. Cook.
Little AS; Balmanno K; Sale MJ; Newman S; Dry JR; Hampson M; Edwards PA; Smith PD; Cook SJ
Sci Signal; 2011; 4(170):er2. PubMed ID: 21674991
[TBL] [Abstract][Full Text] [Related]
31. Relationships among
Wan XB; Wang AQ; Cao J; Dong ZC; Li N; Yang S; Sun MM; Li Z; Luo SX
World J Gastroenterol; 2019 Feb; 25(7):808-823. PubMed ID: 30809081
[TBL] [Abstract][Full Text] [Related]
32. Localization of active, dually phosphorylated extracellular signal-regulated kinase 1 and 2 in colorectal cancer with or without activating BRAF and KRAS mutations.
Holck S; Bonde J; Pedersen H; Petersen AA; Chaube A; Nielsen HJ; Larsson LI
Hum Pathol; 2016 Aug; 54():37-46. PubMed ID: 27036313
[TBL] [Abstract][Full Text] [Related]
33. Extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase pathway is involved in myostatin-regulated differentiation repression.
Yang W; Chen Y; Zhang Y; Wang X; Yang N; Zhu D
Cancer Res; 2006 Feb; 66(3):1320-6. PubMed ID: 16452185
[TBL] [Abstract][Full Text] [Related]
34. Context-Dependent Effects of Amplified MAPK Signaling during Lung Adenocarcinoma Initiation and Progression.
Cicchini M; Buza EL; Sagal KM; Gudiel AA; Durham AC; Feldser DM
Cell Rep; 2017 Feb; 18(8):1958-1969. PubMed ID: 28228261
[TBL] [Abstract][Full Text] [Related]
35. Early and delayed intervention with rapamycin prevents NNK-induced lung adenocarcinoma in A/J mice.
Patlolla JM; Kopelovich L; Qian L; Zhang Y; Kumar G; Madka V; Mohammed A; Biddick L; Sadeghi M; Lightfoot S; Rao CV
Oncol Rep; 2015 Dec; 34(6):2925-34. PubMed ID: 26397133
[TBL] [Abstract][Full Text] [Related]
36. Aberrant promoter hypermethylation of the death-associated protein kinase gene is early and frequent in murine lung tumors induced by cigarette smoke and tobacco carcinogens.
Pulling LC; Vuillemenot BR; Hutt JA; Devereux TR; Belinsky SA
Cancer Res; 2004 Jun; 64(11):3844-8. PubMed ID: 15172992
[TBL] [Abstract][Full Text] [Related]
37. Increased phosphorylation of ERK1/2 is associated with worse chemotherapeutic outcome and a poor prognosis in advanced lung adenocarcinoma.
Tsujino I; Nakanishi Y; Hiranuma H; Shimizu T; Hirotani Y; Ohni S; Ouchi Y; Takahashi N; Nemoto N; Hashimoto S
Med Mol Morphol; 2016 Jun; 49(2):98-109. PubMed ID: 26705127
[TBL] [Abstract][Full Text] [Related]
38. Ki-ras mutations in 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-initiated and butylated hydroxytoluene-promoted lung tumors in A/J mice.
Matzinger SA; Gunning WT; You M; Castonguay A
Mol Carcinog; 1994 Sep; 11(1):42-8. PubMed ID: 7916989
[TBL] [Abstract][Full Text] [Related]
39. Combined antioxidant (beta-carotene, alpha-tocopherol and ascorbic acid) supplementation increases the levels of lung retinoic acid and inhibits the activation of mitogen-activated protein kinase in the ferret lung cancer model.
Kim Y; Chongviriyaphan N; Liu C; Russell RM; Wang XD
Carcinogenesis; 2006 Jul; 27(7):1410-9. PubMed ID: 16401635
[TBL] [Abstract][Full Text] [Related]
40. Methyl-3-indolylacetate inhibits cancer cell invasion by targeting the MEK1/2-ERK1/2 signaling pathway.
Zhang S; Li Z; Wu X; Huang Q; Shen HM; Ong CN
Mol Cancer Ther; 2006 Dec; 5(12):3285-93. PubMed ID: 17172432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
